Data as of Oct 22
| -0.03 / -2.52%|
The 3 analysts offering 12-month price forecasts for StemCells Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 2.50. The median estimate represents a +331.03% increase from the last price of 1.16.
The current consensus among 3 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.